Masitinib
Cat. No.:YN440063
产品名称: | Masitinib |
CAS No.: | 790299-79-5 |
Chemical Name: | 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-benzamide |
Synonyms: | 马赛替尼; AB1010 |
分子量: | 498.64 |
分子式: | C₂₈H₃₀N₆OS |
SMILES: | O=C(NC1=CC=C(C(NC2=NC(C3=CC=CN=C3)=CS2)=C1)C)C4=CC=C(CN5CCN(CC5)C)C=C4 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Masitinib (AB1010) 是一种有效的,生物口服可利用的,且选择性的c-Kit抑制剂 (对于人重组c-Kit,IC50=200 nM),它还抑制PDGFRα/β(IC50s=540/800 nM),Lyn(对 LynB 的IC50=510 nM),Lck,较小程度上抑制FGFR3和FAK。Masitinib (AB1010) 有抗增殖,促凋亡活性,且毒性低。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Dubreuil, P., Letard, S., Ciufolini, M., et al.Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KITPLoS One4(9),e7258(2009)
Drayman, N., DeMarco, J.K., Jones, K.A., et al.Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Science373(6557),931-936(2021)